Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Top Cited Papers
Open Access
- 25 January 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (4), 335-347
- https://doi.org/10.1056/nejmoa061098
Abstract
Invasive fungal infections are an important cause of morbidity and mortality after allogeneic hematopoietic stem-cell transplantation.Keywords
This publication has 36 references indexed in Scilit:
- A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2007
- In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and YeastsAntimicrobial Agents and Chemotherapy, 2006
- Issues in the Design of the Fluconazole Prophylaxis Trials in Patients Undergoing Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2004
- Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplantsBlood, 2004
- Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patientsBritish Journal of Haematology, 2002
- Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative EvaluationAntimicrobial Agents and Chemotherapy, 2001
- A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignanciesBritish Journal of Haematology, 1999
- Systemic Antifungal AgentsDrug Safety, 1998
- Incidence and risk factors for invasive fungal infections in allogeneic BMT recipientsBone Marrow Transplantation, 1997
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992